首页> 外文OA文献 >Post-hoc analysis of randomised, placebo-controlled, double-blind study (MCI186-19) of edaravone (MCI-186) in amyotrophic lateral sclerosis

【2h】

Post-hoc analysis of randomised, placebo-controlled, double-blind study (MCI186-19) of edaravone (MCI-186) in amyotrophic lateral sclerosis

机译：在肌营养的侧面硬化症中的随机，安慰剂控制，双盲研究（MCI-186）的随机，安慰剂，双盲研究（MCI186-19）分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Koji Takei; Fumihiro Takahashi; Shawn Liu; Kikumi Tsuda; Joseph Palumbo;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类
入库时间 2022-08-20 22:01:35

相似文献

外文文献
中文文献
专利

1. Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients [J] . Abe Koji, Itoyama Yasuto, Sobue Gen, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration . 2014,第7a8期

机译：依达拉奉（MCI-186）在肌萎缩性侧索硬化症患者中的有效性和安全性的双盲，平行分组，安慰剂对照研究
2. Post-hoc analyses of the edaravone clinical trials Study 16 and Study 19: a step toward more efficient clinical trial designs in amyotrophic lateral sclerosis [J] . Joseph M. Palumbo, Jean Hubble, Stephen Apple, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration . 2019,第5a6期

机译：埃及龙酮临床试验研究16和研究19：肌营养侧面硬化症更有效的临床试验设计的步骤
3. Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial [J] . William Camu, Marius Mickunas, Jean-Luc Veyrune, EBioMedicine . 2020,第6期

机译：在肌营养的外侧硬化剂（IMODALS）中重复5天的低剂量醛氏蛋白循环：A相随机，双盲，安慰剂对照试验
4. Heuristic principal component analysis-based unsupervised feature extraction and its application to gene expression analysis of amyotrophic lateral sclerosis data sets [C] . Taguchi Y.-H., Iwadate Mitsuo, Umeyama Hideaki IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology . 2015

机译：基于启发式主成分分析的无预测特征提取及其在肌营养侧面硬化数据集的基因表达分析中的应用
5. Image processing tools for quantitative analysis of magnetic resonance neuroimaging and application to amyotrophic lateral sclerosis. [D] . Bigler, Don Charles. 2009

机译：用于磁共振神经成像定量分析的图像处理工具及其在肌萎缩性侧索硬化中的应用。
6. Confirmatory double-blind parallel-group placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients [O] . Koji Abe, Yasuto Itoyama, Gen Sobue, -1

机译：依达拉奉（MCI-186）在肌萎缩性侧索硬化症患者中的有效性和安全性的双盲平行分组安慰剂对照试验研究
7. A safety analysis of edaravone (MCI-186) during the first six cycles (24 weeks) of amyotrophic lateral sclerosis (ALS) therapy from the double-blind period in three randomized, placebo-controlled studies [O] . Alexander Kalin, Elvia Medina-Paraiso, Kaoru Ishizaki, 2017

机译：在三次随机，安慰剂对照研究中的双盲时期前六个循环（24周）埃达拉夫酮（MCI-186）的安全分析

Post-hoc analysis of randomised, placebo-controlled, double-blind study (MCI186-19) of edaravone (MCI-186) in amyotrophic lateral sclerosis

著录项

相似文献

相关主题

期刊订阅